Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy

1. <div><p>Hamdy N.A.T. Strontium ranelate: the logical answer for a living tissue. Osteoporos Int 2007;18(1):177-8.</p><p>Reginster J.-Y., Felsenberg D., Boonen S. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis results of a five-year, randomized, placebo-controlled trial. Arthritis &amp; Rheum 2008;58(6):1687-95.</p><p>Roux C., Fechtenbaum J., Kolta S. et al. Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis. Ann Rheum Dis 2008;67:1736-8.</p><p>Reginster J.Y., Bruyere O., Sawicki A. et al. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years. Bone 2009 (PMD:13679207).</p><p>Blake G.M., Foglman I. Long-Term Effect of Strontium Ranelate treatment on BMD. J Bone Mineral Res 2005;20:1901-4.</p><p>Meunier P.J., Slosman D.O., Delmas P.D. et al. Strontium ranelate: Dosedependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002;87:2060-6.</p><p>Bruyere O., Roux C., Detilleux J. et al. Relationship between Bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 2007;92:3076-81.</p><p>Ortolani S., Diaz-Curiel M. Strontium ranelate: changes in BMD and bone markers one year after treatment discontinuation. Osteoporos Int 2007;18(1):25.</p><p>Collette J., Reginster J.-Y., Bruyere O. et al. Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate. Osteoporos Int 2007;18(1):125.</p><p>Choudhary S., Halbout P., Alander C. et al. Strontium ranelate effects on osteoblastic differentiation are associated with PGE2-dependent growth factor production. Osteoporos Int 2007;18(1):167.</p><p>Brennan T.C., Rybchyn M.S., Conigrave A.D., Mason R.S. Strontium ranelate effects on bone formation and bone resorption: an in vitro in human osteoblasts. Osteoporos Int 2007;18(1):166-7.</p><p>Bonnelye E., Chabadel A., Saltel F., Jurdic P. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008;42:129-38.</p><p>Ammann P., Shen V., Robin B. et al. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 2004;19:2012-20.</p><p>Arlot M. E., Jiang Y., Genant H. K. et al. Histomorphometric and CT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res 2008;23(2):215-22.</p><p>Meunier P.J., Roux C., Seeman E. et al. The effects of strontium ranelate on the risk of vertebral fracture in women with post-menopausal osteoporosis. N Engl J Med 2004;350:459-68.</p><p>Reginster J.Y., Seeman E., De Vernejoul M.C. et al. Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: treatment of peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:2816-22.</p><p>Boivin G., Khebbab M.T., Jaurand X. et al. Localization of strontium, by X-ray microanalysis cartography, in bone biopsies of postmenopausal osteoporotic women treated for 3 years with strontium ranelate. Osteoporos Int 2007;18(1):165-6.</p><p>Marquis P., Roux C., de la Loge C. et al. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int 2008;19:503-10.</p></div><br />